These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25792100)

  • 1. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.
    Engel AG; Shen XM; Selcen D; Sine SM
    Lancet Neurol; 2015 Apr; 14(4):420-34. PubMed ID: 25792100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital myasthenic syndromes in 2012.
    Engel AG
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):92-101. PubMed ID: 21997714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes.
    Barišić N; Chaouch A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2011 May; 15(3):189-96. PubMed ID: 21498094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
    Engel AG; Ohno K; Shen XM; Sine SM
    Ann N Y Acad Sci; 2003 Sep; 998():138-60. PubMed ID: 14592871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital myasthenic syndromes: recent advances.
    Beeson D
    Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of the congenital myasthenic syndromes.
    Engel AG
    Neuromuscul Disord; 2012 Feb; 22(2):99-111. PubMed ID: 22104196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
    Ohno K; Ito M; Masuda A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of congenital myasthenic syndromes.
    Engel AG; Sine SM
    Curr Opin Pharmacol; 2005 Jun; 5(3):308-21. PubMed ID: 15907919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Landscape of Congenital Myasthenic Syndromes From Turkey: Novel Mutations and Clinical Insights.
    Yiş U; Becker K; Kurul SH; Uyanik G; Bayram E; Haliloğlu G; Polat Aİ; Ayanoğlu M; Okur D; Tosun AF; Serdaroğlu G; Yilmaz S; Topaloğlu H; Anlar B; Cirak S; Engel AG
    J Child Neurol; 2017 Jul; 32(8):759-765. PubMed ID: 28464723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital myasthenic syndromes: progress over the past decade.
    Engel AG; Ohno K; Sine SM
    Muscle Nerve; 2003 Jan; 27(1):4-25. PubMed ID: 12508290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital myasthenic syndromes].
    Ohno K
    Rinsho Shinkeigaku; 2012; 52(11):1159-61. PubMed ID: 23196549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
    Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
    Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndromes.
    Eymard B; Hantaï D; Estournet B
    Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
    Engel AG; Ohno K; Sine SM
    Nat Rev Neurosci; 2003 May; 4(5):339-52. PubMed ID: 12728262
    [No Abstract]   [Full Text] [Related]  

  • 20. The spectrum of congenital myasthenic syndromes.
    Engel AG; Ohno K; Sine SM
    Mol Neurobiol; 2002; 26(2-3):347-67. PubMed ID: 12428764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.